Search research articles
Contact Us
Filters
Showing results (61-70 of 136) with videos related to
Page
of 14
Sort By:
Neuroscience
|
July 17, 2024
mGluR5 positive allosteric modulation prevents MK-801 induced increases in extracellular glutamate in the rat medial prefrontal cortex
Amber L LaCrosse, Christina E May, William C Griffin, et al.
Frontiers in Pharmacology
|
January 11, 2012
Differential Modulation of Thresholds for Intracranial Self-Stimulation by mGlu5 Positive and Negative Allosteric Modulators: Implications for Effects on Drug Self-Administration
Richard M Cleva, Lucas R Watterson, Meagan A Johnson, et al.
Expert Opinion on Pharmacotherapy
|
May 28, 2024
Promising immunomodulators for management of substance and alcohol use disorders
Amanda M Acuña, Connor Park, Jonna M Leyrer-Jackson, et al.
Brain, Behavior, and Immunity
|
March 8, 2022
Nuclear factor kappa B signaling within the rat nucleus accumbens core sex-dependently regulates cue-induced cocaine seeking and matrix metalloproteinase-9 expression
Mark D Namba, Megan N Phillips, Janet L Neisewander, et al.
Pharmacology, Biochemistry, and Behavior
|
May 4, 2011
Glutamatergic medications for the treatment of drug and behavioral addictions
M Foster Olive, Richard M Cleva, Peter W Kalivas, et al.
Journal of Addiction Research & Therapy
|
March 20, 2012
The mGluR5 Positive Allosteric Modulator CDPPB Does Not Alter Extinction or Contextual Reinstatement of Methamphetamine-Seeking Behavior in Rats
John J Widholm, Justin T Gass, Richard M Cleva, et al.
Neural Plasticity
|
December 6, 2012
Increases in doublecortin immunoreactivity in the dentate gyrus following extinction of heroin-seeking behavior
Megan P Hicks, Kelly C Wischerath, Amber L Lacrosse, et al.
Pharmaceuticals (Basel, Switzerland)
|
November 27, 2013
NMDA Receptor Modulators in the Treatment of Drug Addiction
Seven E Tomek, Amber L Lacrosse, Natali E Nemirovsky, et al.
Journal of Drug and Alcohol Research
|
June 11, 2016
Effects of modafinil and R-modafinil on brain stimulation reward thresholds: implications for their use in the treatment of psychostimulant dependence
Brian T Burrows, Lucas R Watterson, Meagan A Johnson, et al.
Frontiers in Behavioral Neuroscience
|
January 23, 2024
Editorial: When the prefrontal cortex network goes wrong: the neuroinflammatory impact on behavioral disorders
Jonna M Leyrer-Jackson, Mark D Namba, Mark P Thomas, et al.
Page
of 14
Search research articles
Search
Showing results (61-70 of 136) with videos related to
Sort By:
Page
of 14
Neuroscience
|
July 17, 2024
mGluR5 positive allosteric modulation prevents MK-801 induced increases in extracellular glutamate in the rat medial prefrontal cortex
Amber L LaCrosse, Christina E May, William C Griffin, et al.
Frontiers in Pharmacology
|
January 11, 2012
Differential Modulation of Thresholds for Intracranial Self-Stimulation by mGlu5 Positive and Negative Allosteric Modulators: Implications for Effects on Drug Self-Administration
Richard M Cleva, Lucas R Watterson, Meagan A Johnson, et al.
Expert Opinion on Pharmacotherapy
|
May 28, 2024
Promising immunomodulators for management of substance and alcohol use disorders
Amanda M Acuña, Connor Park, Jonna M Leyrer-Jackson, et al.
Brain, Behavior, and Immunity
|
March 8, 2022
Nuclear factor kappa B signaling within the rat nucleus accumbens core sex-dependently regulates cue-induced cocaine seeking and matrix metalloproteinase-9 expression
Mark D Namba, Megan N Phillips, Janet L Neisewander, et al.
Pharmacology, Biochemistry, and Behavior
|
May 4, 2011
Glutamatergic medications for the treatment of drug and behavioral addictions
M Foster Olive, Richard M Cleva, Peter W Kalivas, et al.
Journal of Addiction Research & Therapy
|
March 20, 2012
The mGluR5 Positive Allosteric Modulator CDPPB Does Not Alter Extinction or Contextual Reinstatement of Methamphetamine-Seeking Behavior in Rats
John J Widholm, Justin T Gass, Richard M Cleva, et al.
Neural Plasticity
|
December 6, 2012
Increases in doublecortin immunoreactivity in the dentate gyrus following extinction of heroin-seeking behavior
Megan P Hicks, Kelly C Wischerath, Amber L Lacrosse, et al.
Pharmaceuticals (Basel, Switzerland)
|
November 27, 2013
NMDA Receptor Modulators in the Treatment of Drug Addiction
Seven E Tomek, Amber L Lacrosse, Natali E Nemirovsky, et al.
Journal of Drug and Alcohol Research
|
June 11, 2016
Effects of modafinil and R-modafinil on brain stimulation reward thresholds: implications for their use in the treatment of psychostimulant dependence
Brian T Burrows, Lucas R Watterson, Meagan A Johnson, et al.
Frontiers in Behavioral Neuroscience
|
January 23, 2024
Editorial: When the prefrontal cortex network goes wrong: the neuroinflammatory impact on behavioral disorders
Jonna M Leyrer-Jackson, Mark D Namba, Mark P Thomas, et al.
Page
of 14